A Phase I/II Double-blind Safety and Efficacy Evaluation of Nowarta110 in Patients With Plantar Warts
Status:
Completed
Trial end date:
2015-12-01
Target enrollment:
Participant gender:
Summary
To evaluate drug safety and efficacy in patients treated with Nowarta110 and to determine
therapeutic activity against Plantar Warts
- Clinical Tolerance
- Clinical Recovery
- Evaluate Safety